The U.S. Supreme Court struck down Zimmer Biomet's request for the high court to review the scope of the damages awarded in a patent infringement case against Stryker. The $248M judgment was one of the largest ever awarded for enhanced patent damages and could have broad ramifications for the entire industry.
Medtronic filed for FDA approval of its InterStim Micro sacral neuromodulation (SNM) device for bladder-related issues and fecal incontinence. The SNM market, which Medtronic monopolized for 20 years, has a fiesty newcomer (Axonics) ready to take the market by storm.
Brand new data shows Grail's liquid biopsy test detects more than 20 cancer types across all stages with a single, very low false-positive rate. The test also identifies where cancer's tissue of origin with high accuracy.